Business Case Biodiversity
summary
Argues a concrete business case using a 4R framework — Regulation, Reputation, Resilience, Return — and cites facts: 50% of pharma products are natural, an ECB study finding 75% of eurozone corporate loans face biodiversity risk, and a supermarket test that left 60% of shelves emptied when pollinator‑dependent goods were removed. Recommends nature‑based carbon credits with high biodiversity impact and community involvement, promotes footprint/handprint/heartprint actions, and describes a new coalition and breakout session to operationalize these solutions.
AI-written summary · about
